Conditions

close

result 859 件

FullText URL fulltext.pdf
Author Li, Yuying| Wang, Qiong| Jia, Huimin| Ishikawa, Kazuya| Kosami, Ken-Ichi| Ueba, Takahiro| Tsujimoto, Atsumi| Yamanaka, Miki| Yabumoto, Yasuyuki| Miki, Daisuke| Sasaki, Eriko| Fukao, Yoichiro| Fujiwara, Masayuki| Kaneko-Kawano, Takako| Tan, Li| Kojima, Chojiro| Wing, Rod A.| Sebastian, Alfino| Nishimura, Hideki| Fukada, Fumi| Niu, Qingfeng| Shimizu, Motoki| Yoshida, Kentaro| Terauchi, Ryohei| Shimamoto, Ko| Kawano, Yoji|
Note The version of record of this article, first published in Nature Communications, is available online at Publisher’s website: http://dx.doi.org/10.1038/s41467-024-48943-5|
Published Date 2024-05-30
Publication Title Nature Communications
Volume volume15
Issue issue1
Publisher Nature Portfolio
Start Page 4610
ISSN 2041-1723
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2024
File Version publisher
PubMed ID 38816417
DOI 10.1038/s41467-024-48943-5
Web of Science KeyUT 001236316700012
Related Url isVersionOf https://doi.org/10.1038/s41467-024-48943-5
JaLCDOI 10.18926/AMO/67204
FullText URL 78_3_285.pdf
Author Hirano, Shuichiro| Otani, Yoshihiro| Fujii, Kentaro| Date, Isao|
Abstract Organized chronic subdural hematoma (OCSDH) is a relatively rare condition that forms over a longer period of time compared to chronic subdural hematoma and is sometimes difficult to diagnose with preoperative imaging. We resected an intracranial lesion in a 37-year-old Japanese man; the lesion had been increasing in size for >17 years. The preoperative diagnosis based on imaging findings was meningioma; however, pathological findings revealed OCSDH. Clinicians should be aware that OCSDH mimics other tumors and consider surgical strategies for this disease.
Keywords meningioma organized chronic subdural hematoma
Amo Type Case Report
Publication Title Acta Medica Okayama
Published Date 2024-06
Volume volume78
Issue issue3
Publisher Okayama University Medical School
Start Page 285
End Page 290
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38902217
Web of Science KeyUT 001267351900002
JaLCDOI 10.18926/AMO/67195
FullText URL 78_3_205.pdf
Author Hagiya, Hideharu|
Abstract The global pandemic of COVID-19 has underscored the significance of establishing and sustaining a practical and efficient infection control system for the benefit and welfare of society. Infectious disease (ID) specialists are expected to take on leadership roles in enhancing organizational infrastructures for infection prevention and control (IPC) at the hospital, community, and national levels. However, due to an absolute shortage and an uneven distribution, many core hospitals currently lack the ID specialists. Given the escalating global risk of emerging and re-emerging infectious diseases as well as antimicrobial resistance pathogens, the education and training of ID specialists constitutes an imperative concern. As demonstrated by historical changes in the healthcare reimbursement system, the establishment and enhancement of IPC measures is pivotal to ensuring medical safety. The existing structure of academic society-driven certification and training initiatives for ID specialists, contingent upon the discretionary decisions of individual physicians, possesses both quantitative and qualitative shortcomings. In this article, I first address the present situations and challenges related to ID specialists and then introduce my idea of securing ID specialists based on the new concepts and platforms; (i) ID Specialists as National Credentials, (ii) Establishment of the Department of Infectious Diseases in Medical and Graduate Schools, (iii) Endowed ID Educative Courses Funded by Local Government and Pharmaceutical Companies, and (iv) Recruitment of Young Physicians Engaged in Healthcare Services in Remote Areas. As clarified by the COVID-19 pandemic, ID specialists play a crucial role in safeguarding public health. Hopefully, this article will advance the discussion and organizational reform for the education and training of ID specialists.
Keywords antimicrobial resistance emerging infectious diseases infection prevention and control medical education silent pandemic
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2024-06
Volume volume78
Issue issue3
Publisher Okayama University Medical School
Start Page 205
End Page 213
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38902208
Web of Science KeyUT 001267351000001
FullText URL fulltext.pdf
Author Vo, Quan Duy| Saito, Yukihiro| Ida, Toshihiro| Nakamura, Kazufumi| Yuasa, Shinsuke|
Published Date 2024-05-21
Publication Title PLoS ONE
Volume volume19
Issue issue5
Publisher Public Library of Science
Start Page e0302537
ISSN 1932-6203
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 Vo et al.
File Version publisher
PubMed ID 38771829
DOI 10.1371/journal.pone.0302537
Web of Science KeyUT 001228816000059
Related Url isVersionOf https://doi.org/10.1371/journal.pone.0302537
FullText URL K0006986_abstract_review.pdf K0006986_fulltext.pdf K0006986_summary.pdf
Author MORIMOTO, Kosaku|
Published Date 2024-03-25
Content Type Thesis or Dissertation
Grant Number 甲第6986号
Granted Date 2024-03-25
Thesis Type Doctor of Philosophy in Medical Science
Grantor 岡山大学
language English
Copyright Holders © The Author(s), 2023.
FullText URL fulltext.pdf
Author Eguchi, Ritsuko| Sekhar, Halubai| Kimura, Koji| Masai, Hirokazu| Happo, Naohisa| Ikeda, Mitsuki| Yamamoto, Yuki| Utsumi, Masaki| Goto, Hidenori| Takabayashi, Yasuhiro| Tajiri, Hiroo| Hayashi, Koichi| Kubozono, Yoshihiro|
Published Date 2024-05-01
Publication Title ACS Omega
Volume volume9
Issue issue19
Publisher American Chemical Society
Start Page 21287
End Page 21297
ISSN 2470-1343
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 The Authors.
File Version publisher
PubMed ID 38764676
DOI 10.1021/acsomega.4c01395
Web of Science KeyUT 001228034300001
Related Url isVersionOf https://doi.org/10.1021/acsomega.4c01395
FullText URL fulltext.pdf
Author Sakamoto, Hirotaka| Inutsuka, Ayumu|
Keywords GFP with a palmitoylation signal (palGFP) plasmalemma localization neurosecretory vesicle immunoelectron microscopy oxytocin
Published Date 2024-04-25
Publication Title ACTA HISTOCHEMICA ET CYTOCHEMICA
Volume volume57
Issue issue2
Publisher The Japan Society of Histochemistry and Cytochemistry
Start Page 85
End Page 88
ISSN 0044-5991
NCID AA00508022
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 The Japan Society of Histochemistry and Cytochemistry
File Version publisher
PubMed ID 38695035
DOI 10.1267/ahc.24-00001
Web of Science KeyUT 001223234800003
Related Url isVersionOf https://doi.org/10.1267/ahc.24-00001
FullText URL fulltext20240512-01.pdf
Author Zhai, Yun| Morihara, Ryuta| Feng, Tian| Hu, Xinran| Fukui, Yusuke| Bian, Zhihong| Bian, Yuting| Yu, Haibo| Sun, Hongming| Takemoto, Mami| Nakano, Yumiko| Yunoki, Taijun| Tang, Ying| Ishiura, Hiroyuki| Yamashita, Toru|
Keywords Alzheimer's disease Hypoperfusion Cerebral vascular remodeling Scallop-derived plasmalogen pSTAT3/PIM1/NFATc1 axis
Note © 2024 Elsevier B.V. This manuscript version is made available under the CC-BY-NC-ND 4.0 license https://creativecommons.org/licenses/by-nc-nd/4.0/| This fulltext file will be available in Jan. 2025.|
Published Date 2024-04-01
Publication Title Brain Research
Volume volume1828
Publisher Elsevier BV
Start Page 148790
ISSN 0006-8993
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2024 Elsevier B.V.
File Version author
PubMed ID 38272156
DOI 10.1016/j.brainres.2024.148790
Web of Science KeyUT 001173928400001
Related Url isVersionOf https://doi.org/10.1016/j.brainres.2024.148790
FullText URL fulltext.pdf
Author Sudoh, Taku| Ikeda, Shuhei| Shigenobu, Keisuke| Tsuzuki, Seiji| Dokko, Kaoru| Watanabe, Masayoshi| Shinoda, Wataru| Ueno, Kazuhide|
Published Date 2023-06-20
Publication Title The Journal of Physical Chemistry C
Volume volume127
Issue issue25
Publisher American Chemical Society (ACS)
Start Page 12295
End Page 12303
ISSN 1932-7447
NCID AA1217589X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © 2023 The Authors.
File Version publisher
DOI 10.1021/acs.jpcc.3c02112
Web of Science KeyUT 001016710400001
Related Url isVersionOf https://doi.org/10.1021/acs.jpcc.3c02112
FullText URL fulltext.pdf
Author Obayashi, Ippei| Yoshiwaki, Michio|
Keywords Topological data analysis Persistent homology Algorithm Algebraic topology
Note The version of record of this article, first published in Discrete & Computational Geometry, is available online at Publisher’s website: http://dx.doi.org/10.1007/s00454-023-00544-7|
Published Date 2023-08-18
Publication Title Discrete & Computational Geometry
Volume volume70
Issue issue3
Publisher Springer Science and Business Media LLC
Start Page 645
End Page 670
ISSN 0179-5376
NCID AA1067900X
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
DOI 10.1007/s00454-023-00544-7
Web of Science KeyUT 001051805700002
Related Url isVersionOf https://doi.org/10.1007/s00454-023-00544-7
FullText URL fulltext.pdf
Author Hochi, Hiroaki| Kubota, Satoshi| Takigawa, Masaharu| Nishida, Takashi|
Published Date 2023-08-17
Publication Title Carcinogenesis
Volume volume44
Issue issue8-9
Publisher Oxford University Press (OUP)
Start Page 695
End Page 707
ISSN 0143-3334
NCID AA00141799
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37590989
DOI 10.1093/carcin/bgad057
Web of Science KeyUT 001061431500001
Related Url isVersionOf https://doi.org/10.1093/carcin/bgad057
FullText URL fulltext.pdf
Author Nakamura, Keiichiro| Matsuoka, Hirofumi| Yorimitsu, Masae| Ogawa, Mariko| Kanemori, Miho| Sueoka, Kotaro| Kozai, Ayumi| Nakamura, Hiroko| Haruma, Tomoko| Shiroyama, Yuko| Hayata, Yuu| Sugii, Hirokazu| Ueda, Akiko| Kurihara, Shuichi| Urayama, Saiko| Shimizu, Miyuki| Masuyama, Hisashi|
Keywords olaparib olaparib plus bevacizumab niraparib renal function
Published Date 2023-09-14
Publication Title Japanese Journal of Clinical Oncology
Volume volume54
Issue issue1
Publisher Oxford University Press (OUP)
Start Page 31
End Page 37
ISSN 1465-3621
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37721176
DOI 10.1093/jjco/hyad125
Web of Science KeyUT 001068527100001
Related Url isVersionOf https://doi.org/10.1093/jjco/hyad125
FullText URL fulltext.pdf
Author Nakamura, Keiichiro| Matsuoka, Hirofumi| Kubo, Kotaro| Shirakawa, Shinsuke| Ida, Naoyuki| Haraga, Junko| Ogawa, Chikako| Okamoto, Kazuhiro| Nagao, Shoji| Masuyama, Hisashi|
Keywords returning to the same workplace gynecologic neoplasms sick leave
Published Date 2023-11-23
Publication Title Japanese Journal of Clinical Oncology
Volume volume54
Issue issue3
Publisher Oxford University Press (OUP)
Start Page 292
End Page 296
ISSN 1465-3621
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023.
File Version publisher
PubMed ID 37995280
DOI 10.1093/jjco/hyad159
Web of Science KeyUT 001108594700001
Related Url isVersionOf https://doi.org/10.1093/jjco/hyad159
FullText URL fulltext.pdf
Author Nagao, Shoji| Tamura, Jun| Shibutani, Takashi| Miwa, Maiko| Kato, Tomoyasu| Shikama, Ayumi| Takei, Yuji| Kamiya, Natsuko| Inoue, Naoki| Nakamura, Kazuto| Inoue, Aya| Yamamoto, Koji| Fujiwara, Keiichi| Suzuki, Mitsuaki|
Keywords Neoadjuvant chemotherapy Epithelial ovarian cancer Adjuvant chemotherapy Interval debulking surgery Primary debulking surgery
Note The version of record of this article, first published in International Journal of Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10147-023-02329-7|
Published Date 2023-05-04
Publication Title International Journal of Clinical Oncology
Volume volume28
Issue issue6
Publisher Springer Science and Business Media LLC
Start Page 804
End Page 815
ISSN 1341-9625
NCID AA11086579
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 37140771
DOI 10.1007/s10147-023-02329-7
Web of Science KeyUT 000980331700002
Related Url isVersionOf https://doi.org/10.1007/s10147-023-02329-7
FullText URL fulltext.pdf
Author Ishiura, Hiroyuki| Tsuji, Shoji| Toda, Tatsushi|
Note The version of record of this article, first published in Journal of Human Genetics, is available online at Publisher’s website: http://dx.doi.org/10.1038/s10038-022-01116-y|
Published Date 2023-01-20
Publication Title Journal of Human Genetics
Volume volume68
Issue issue3
Publisher Springer Science and Business Media LLC
Start Page 169
End Page 174
ISSN 1434-5161
NCID AA11206160
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2023
File Version publisher
PubMed ID 36670296
DOI 10.1038/s10038-022-01116-y
Web of Science KeyUT 000916021000001
Related Url isVersionOf https://doi.org/10.1038/s10038-022-01116-y
JaLCDOI 10.18926/AMO/66927
FullText URL 78_2_185.pdf
Author Takahashi, Hiroko| Eguchi, Jun| Watanabe, Mayu| Nakayama, Masanori| Wada, Jun|
Abstract The global pandemic of coronavirus infection 2019 (COVID-19) was an unprecedented public health emergency. Several clinical studies reported that heart disease, lung disease, diabetes, hypertension, dyslipidemia, and obesity are critical risk factors for increased severity of and hospitalization for COVID-19. This is largely because patients with these underlying medical conditions can show poor immune responses to the COVID-19 vaccinations. Diabetes is one of the underlying conditions most highly associated with COVID-19 susceptibility and is considered a predictor of poor prognosis of COVID-19. We therefore investigated factors that influence the anti-SARS-CoV-2 spike IgG antibody titer after three doses of vaccination in patients with type 2 diabetes. We found that obesity was associated with low anti-SARS-CoV-2 spike IgG antibody titers following three-dose vaccination in type 2 diabetics. Obese patients with type 2 diabetes may have attenuated vaccine efficacy and require additional vaccination; continuous infection control should be considered in such patients.
Keywords obesity type 2 diabetes COVID-19 vaccination
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 185
End Page 191
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688836
Web of Science KeyUT 001227932200002
JaLCDOI 10.18926/AMO/66924
FullText URL 78_2_151.pdf
Author Komatsubara, Tadashi| Tazawa, Hiroshi| Hasei, Joe| Omori, Toshinori| Sugiu, Kazuhisa| Mochizuki, Yusuke| Demiya, Koji| Yoshida, Aki| Fujiwara, Tomohiro| Kunisada, Toshiyuki| Urata, Yasuo| Kagawa, Shunsuke| Ozaki, Toshifumi| Fujiwara, Toshiyoshi|
Abstract Soft-tissue sarcoma (STS) is a heterogeneous group of rare tumors originating predominantly from the embryonic mesoderm. Despite the development of combined modalities including radiotherapy, STSs are often refractory to antitumor modalities, and novel strategies that improve the prognosis of STS patients are needed. We previously demonstrated the therapeutic potential of two telomerase-specific replication-competent oncolytic adenoviruses, OBP-301 and tumor suppressor p53-armed OBP-702, in human STS cells. Here, we demonstrate in vitro and in vivo antitumor effects of OBP-702 in combination with ionizing radiation against human STS cells (HT1080, NMS-2, SYO-1). OBP-702 synergistically promoted the antitumor effect of ionizing radiation in the STS cells by suppressing the expression of B-cell lymphoma-X large (BCL-xL) and enhancing ionizing radiation-induced apoptosis. The in vivo experiments demonstrated that this combination therapy significantly suppressed STS tumors’ growth. Our results suggest that OBP-702 is a promising antitumor reagent for promoting the radiosensitivity of STS tumors.
Keywords soft-tissue sarcoma radiotherapy oncolytic adenovirus p53 BCL-xL
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 151
End Page 161
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688833
Web of Science KeyUT 001229151800007
FullText URL fulltext.pdf
Author Kitamura, Wataru| Kuratsune, Masatoshi| Iseki, Akiko| Kuyama, Shoichi|
Published Date 2024-03-27
Publication Title Rheumatology Advances in Practice
Volume volume8
Issue issue2
Publisher Oxford University Press
Start Page rkae045
ISSN 2514-1775
Content Type Journal Article
language English
OAI-PMH Set 岡山大学
Copyright Holders © The Author(s) 2024.
File Version publisher
PubMed ID 38618140
DOI 10.1093/rap/rkae045
Web of Science KeyUT 001201694800001
Related Url isVersionOf https://doi.org/10.1093/rap/rkae045
JaLCDOI 10.18926/AMO/66915
FullText URL 78_2_123.pdf
Author Saeki, Kyosuke| Fujiwara, Hideaki| Seike, Keisuke| Kuroi, Taiga| Nishimori, Hisakazu| Tanaka, Takehiro| Matsuoka, Ken-ichi| Fujii, Nobuharu| Maeda, Yoshinobu|
Abstract Chronic graft-versus-host disease (GVHD) is a major cause of late death and morbidity following allogeneic hematopoietic cell transplantation (HCT), but its pathogenesis remains unclear. Recently, haplo-identical HCT with post-transplant cyclophosphamide (Haplo-HCT with PTCY) was found to achieve a low incidence rate of acute GVHD and chronic GVHD. However, while the pathogenesis of acute GVHD following Haplo-HCT with PTCY has been well investigated, that of chronic GVHD remains to be elucidated, especially in HLA-matched HCT with PTCY. Based on its safety profile, PTCY is currently applied for the human leucocyte antigen (HLA)-matched HCT setting. Here, we investigated the mechanisms of chronic GVHD following HLA-matched HCT with PTCY using a well-defined mouse chronic GVHD model. PTCY attenuated clinical and pathological chronic GVHD by suppressing effector T-cells and preserving regulatory T-cells compared with a control group. Additionally, we demonstrated that cyclosporine A (CsA) did not show any additional positive effects on attenuation of GVHD in PTCY-treated recipients. These results suggest that monotherapy with PTCY without CsA could be a promising strategy for the prevention of chronic GVHD following HLA-matched HCT.
Keywords GVHD posttransplant cyclophosphamide hematopoietic cell transplantation HLA-identical
Amo Type Original Article
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 123
End Page 134
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688830
Web of Science KeyUT 001229151800004
JaLCDOI 10.18926/AMO/66912
FullText URL 78_2_095.pdf
Author Itano, Junko| Kiura, Katsuyuki| Maeda, Yoshinobu| Miyahara, Nobuaki|
Abstract The lungs are very complex organs, and the respiratory system performs the dual roles of repairing tissue while protecting against infection from various environmental stimuli. Persistent external irritation disrupts the immune responses of tissues and cells in the respiratory system, ultimately leading to respiratory disease. Neuropeptide Y (NPY) is a 36-amino-acid polypeptide and a neurotransmitter that regulates homeostasis. The NPY receptor is a seven-transmembrane-domain G-protein-coupled receptor with six subtypes (Y1, Y2, Y3, Y4, Y5, and Y6). Of these receptors, Y1, Y2, Y4, and Y5 are functional in humans, and Y1 plays important roles in the immune responses of many organs, including the respiratory system. NPY and the Y1 receptor have critical roles in the pathogenesis of asthma, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The effects of NPY on the airway immune response and pathogenesis differ among respiratory diseases. This review focuses on the involvement of NPY in the airway immune response and pathogenesis of various respiratory diseases.
Keywords neuropeptide y Y1 receptor airway immune response bronchial epithelial cells respiratory disease
Amo Type Review
Publication Title Acta Medica Okayama
Published Date 2024-04
Volume volume78
Issue issue2
Publisher Okayama University Medical School
Start Page 95
End Page 106
ISSN 0386-300X
NCID AA00508441
Content Type Journal Article
language English
Copyright Holders Copyright Ⓒ 2024 by Okayama University Medical School
File Version publisher
Refereed True
PubMed ID 38688827
Web of Science KeyUT 001229151800001